Obesity associated with improved mortality of extracorporeal membrane oxygenation for severe COVID-19 pneumonia.
Navin R PrasadKhaled ElkholeyNilay R PatelErica JunqueiraElliott S CohenSage P WhitmorePublished in: Perfusion (2023)
In patients receiving ECMO for severe COVID-19, neither obesity (BMI >30) nor morbid obesity (BMI >40) were associated with in-hospital mortality. These results are consistent with previous reports and held true after adjusting for age and comorbidities. Our data suggest further examination of the recommendations to withhold ECMO in patients who are obese.
Keyphrases
- extracorporeal membrane oxygenation
- weight loss
- acute respiratory distress syndrome
- metabolic syndrome
- weight gain
- respiratory failure
- insulin resistance
- coronavirus disease
- type diabetes
- sars cov
- high fat diet induced
- bariatric surgery
- end stage renal disease
- body mass index
- early onset
- ejection fraction
- mechanical ventilation
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- chronic kidney disease
- cardiovascular events
- cardiovascular disease
- clinical practice
- obese patients
- risk factors
- drug induced
- patient reported outcomes
- intensive care unit
- electronic health record
- emergency department
- respiratory syndrome coronavirus
- adverse drug
- data analysis